Antiretroviral drug-drug interactions: A comparison of online drug interaction databases COMMENT

被引:7
|
作者
Drwiega, Emily N. [1 ]
Badowski, Melissa E. [1 ]
Michienzi, Sarah [1 ]
机构
[1] Univ Illinois, Coll Pharm, 833 S Wood St, Chicago, IL 60612 USA
关键词
antiretroviral therapy; drug-drug interaction; OLDER;
D O I
10.1111/jcpt.13750
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objective: Antiretrovirals have a high drug interaction potential, which can lead to increased toxicity and/or decreased efficacy. Multiple databases are available to assess drug-drug interactions. The aim of our study was to compare interaction identification for commonly used ARVs and concomitant medications between six different online drug-drug interaction databases. Comment: This was a cross-sectional review using each of the following six databases: LexiComp (R), Clinical Pharmacology (R), Micromedex (R), Epocrates (R), University of Liverpool, and University of Toronto. Sixteen antiretroviral drugs and 100 of the DrugStats Database "Top 200 of 2019" list of medications were included. Each of the six databases identified a different number of actual or potential interactions. The number of interactions ranged from 211 to 283. What is new and conclusions: A variety of databases exist with inconsistent identification of actual or potential drug-drug interactions amongst them. It may be beneficial to cross-reference multiple databases prior to making decisions regarding patient care.
引用
收藏
页码:1720 / 1724
页数:5
相关论文
共 50 条
  • [1] DRUG-DRUG INTERACTION DATABASES: SENSITIVITY AND SPECIFICITY TO DETECT MANIFEST DRUG-DRUG INTERACTIONS, RELIABILITY RATINGS AND MANAGEMENT STRATEGIES OF POTENTIAL DRUG-DRUG INTERACTIONS
    Ocovska, Z.
    Marikova, M.
    Kukralova, K.
    Vlcek, J.
    VALUE IN HEALTH, 2022, 25 (01) : S140 - S141
  • [2] Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
    Hecker, Michael
    Frahm, Niklas
    Bachmann, Paula
    Debus, Jane Louisa
    Haker, Marie-Celine
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Baldt, Julia
    Streckenbach, Barbara
    Heidler, Felicita
    Zettl, Uwe Klaus
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Antiretroviral and Statin Drug-Drug Interactions
    Ray, Gretchen M.
    CARDIOLOGY IN REVIEW, 2009, 17 (01) : 44 - 47
  • [4] Antiretroviral and immunosuppressive drug-drug interactions: An update
    Izzedine, H
    Launay-Vacher, V
    Baumelou, A
    Deray, G
    KIDNEY INTERNATIONAL, 2004, 66 (02) : 532 - 541
  • [5] Antiretroviral drug-drug interactions in an era of polypharmacy
    Back, David
    GERMS, 2019, 9 (03): : 123 - 124
  • [6] Antiretroviral therapies and corticosteroids Drug-drug interactions
    Cadet, Myriam Jean
    NURSE PRACTITIONER, 2021, 46 (12): : 40 - 47
  • [7] Additional antiretroviral and immunosuppressive drug-drug interactions
    Busti, AJ
    KIDNEY INTERNATIONAL, 2004, 66 (06) : 2469 - 2469
  • [8] Drug-drug interactions in an intensive care unit and comparison of updates in two databases
    Riera, Pau
    Sole, Nuria
    Carlos Suarez, Juan
    Andrea Lopez, Paula
    Fonts, Nuria
    Rodriguez-Farre, Nuria
    Fernandez de Gamarra-Martinez, Edurne
    Moran, Indalecio
    FARMACIA HOSPITALARIA, 2022, 46 (05) : 290 - 295
  • [9] Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions
    Gex-Fabry, M
    Balant-Gorgia, AE
    Balant, LP
    DRUG SAFETY, 2001, 24 (13) : 947 - 959
  • [10] Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
    Marianne Gex-Fabry
    Luc P. Balant
    Androniki E. Balant-Gorgia
    Drug Safety, 2001, 24 : 947 - 959